# Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer

> **NCT00521521** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 86 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DRUG:** docetaxel and cisplatin
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00521521
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2006-05
- **Final completion:** —
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521521, "Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT00521521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*